Gen2 Neuroscience
Gen2 Neuroscience develops therapeutics for the treatment of dementia targeting abnormal forms of the essential cellular protein tau.
Follow Gen2 Neuroscience and see its new rounds in your feed.Sign up free
Listed
Biotechnology in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Gen2 Neuroscience in front of investors. Or tell us what we have wrong.